• About
  • Research
  • MSCA blog - cont'd
  • Outreach
  Tobias Buchborn
Online lectures/interviews

Picture
Pharmacology - What happens when LSD permeates your brain? (in German)

Picture
Psychology - Psychedelics, therapy, and personality   (in German)


Upcoming public lecture(s)
  • To be announced

Past public lectures/presentations
  • IZN Retreat (Kloster Schoental [Germany], 2022). Psychedelics in basic and preclinical research (see: uni-heidelberg.de).
  • Brazilian-German Frontiers of Science and Technology Symposium, Humboldt Stiftung (Maceio [Brazil], 2022): Kicking the habit while  tripping – Psilocybin in the treatment of alcohol addiction (see: abc.org.br).
  • Interdisciplinary Conference on Psychedelic Research (Harlem [Netherlands], 2020): Microdosing - Introduction to the pharmacodynamics of repeated psychedelic-drug intake (see: icpr2020.net).               
  • Breaking convention (London, Univ. Greenwich [England], 2019): Using optogenetics to shine a light on the motor cortical embedding of the “psychedelic signature move” (ABSTRACT).
  • Lecture series “Amsterdam Psychedelic Research Association (APRA)” (VU Univ. Amsterdam [Netherlands], 2019): Prolonged Intake of Psychedelics: Tolerance and other Sequelae (see: apraresearch.wordpress.com).
  • Interdisciplinary Conference on Psychedelic Research (Amsterdam [Netherlands], 2016): Differential tolerance to hyperthermia induced by LSD and DMT is paralleled by differential desensitisation of frontocortical, but not hypothalamic serotonin 2 receptors (ABSTRACT).
  • German Pharm-Tox Summit (Free Univ. Berlin [Germany], 2016): Differential tolerance to LSD and DMT – A matter of serotonin (5-HT) 2A receptor downregulation?
  • Psychedelics – Novel Applications for Depression (Univ. Utrecht [Netherlands], 2015): LSD and the treatment of depression (see: stichtingopen.nl).
  • DGPT (German association for Experimental and Clinical Pharmacology and Toxicology) conference (Univ. of Techn. Dresden [Germany], 2012): Agonist-selective internalization of the human 5-HT2A receptor.
  • World Psychedelic Forum (Basel [Switzerland], 2008): LSD as experimental antidepressant in Rats.

Past universitary lectures
  • Lecture series “UCL Society for the Application of Psychedelics (UCL-SAP, London [England], 2019)” (UCL, London [UK]). Optogenetic light on psychedelic drug action (for further information: facebook.com)
  • Lecture series “Neuroscience in Mental Health – Psychopharmacology” (UCL, London [England], 2018): Introduction to the Neuropharmacology of serotonergic hallucinogens.
  • Lecture series “Addiction and Neuropsychopharmacology in Psychiatry” (ICL, London [England], 2017): Tolerance to serotonergic hallucinogens.

Blog contributions
  • Buchborn (2021). Tolerance to LSD - How the brain bolts the doors of perception (see: mind-foundation.org).
  • Buchborn (2019). Discussing tolerance with Dr. Buchborn (see: apraresearch.wordpress.com).

Podcast contributions
  • Buchborn @ Set & Setting (2022). Wie LSD dein Gehirn beeinflusst! Die Funktionsweise von Psychedelika erklärt mit Dr. Tobias Buchborn (see: setandsetting.de).
  • Buchborn @ Set & Setting (2022). Mit Psychedelika ins Unterbewusstsein! Eine Reise durch die Psyche mit Dr. Tobias Buchborn (see: setandsetting.de).